 | • レポートコード：B-MOR-08088 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、胸部イメージングの世界市場について調べ、胸部イメージングの世界規模、市場動向、市場環境、イメージングモダリティのタイプ別（マンモグラフィー、MRI、トモシンセシス、超音波、分子イメージング、光学イメージング、造影法、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・胸部イメージングの世界市場インサイト ・胸部イメージングの世界市場環境 ・胸部イメージングの世界市場動向 ・胸部イメージングの世界市場規模 ・胸部イメージングの世界市場規模：イメージングモダリティのタイプ別（マンモグラフィー、MRI、トモシンセシス、超音波、分子イメージング、光学イメージング、造影法、その他） ・胸部イメージングの世界市場：地域別市場規模・分析 ・胸部イメージングの北米市場規模・予測 ・胸部イメージングのアメリカ市場規模・予測 ・胸部イメージングのヨーロッパ市場規模・予測 ・胸部イメージングのアジア市場規模・予測 ・胸部イメージングの日本市場規模・予測 ・胸部イメージングの中国市場規模・予測 ・胸部イメージングのインド市場規模・予測 ・胸部イメージングの韓国市場規模・予測 ・関連企業情報・競争状況 |
The breast cancer imaging Market is expected to register a CAGR of about 8.5%, during the forecast period, 2018 to 2023. North America dominates the market, due to growing amount of technological advancements, and accessibility and awareness of breast cancer. Breast cancer is anticipated to be the preliminary driver of the breast imaging market. According to a report by the UNICEF, breast cancer is the most communal cancer observed in the women globally. Therefore, the demand of these products is anticipated to increase during the forecast period.
Governments Efforts to Increase Awareness
Breast cancer is the leading cause for the growth of the breast imaging market. Spreading awareness about breast cancer is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment. Breast cancer advocates raise funds and lobby for better care, more knowledge, and more patient empowerment. They conduct educational campaigns or provide free or low-cost services. This along with other factors, such as R&D in Breast Cancer Diagnostics will help drive the breast imaging market.
Errors and Side Effects Associated with Breast Screening
The main risk of mammograms is that they do not provide perfect diagnosis. Normal breast tissue can hide a breast cancer so that it doesn’t show up on the mammogram. This is called a false negative. And mammography can identify an abnormality that looks, like a cancer, but turns out to be normal. This is called a false positive. Besides worrying about being diagnosed with breast cancer, a false positive means more tests and follow-up visits, which can be stressful. To make up for these limitations, more than mammography is often needed. Women also need to practice breast self-examination, get regular breast examinations by an experienced health care professional, and, in some cases, also get another form of breast imaging, such as breast MRI or ultrasound. Since, mammography is the most common form of breast imaging it will act as a restraint for the breast imaging market along with factors, like high cost of imaging systems and stringent regulation
High Growth Rate of Market in APAC
North America is estimated to be the largest regional segment in the global breast imaging market in 2016, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 9.5% from 2016 to 2021. A number of factors, such as the growing patient population, increasing healthcare expenditure, improving healthcare infrastructure, growing government spending on breast cancer research studies, and implementation of several initiatives to create awareness about the early detection of breast cancer are expected to drive the market in the Asia-Pacific region.
Key Developments in the Market
• September 2017 – A newer type of mammogram is known as breast tomosynthesis or 3D mammography. For this test, a machine takes many low-dose x-rays as it moves over the breast. A computer then puts the images together into a 3-dimensional picture. For more on this test, see Mammogram Basics
Major players – BARCO, DILON DIAGNOSTICS, DUNE, GE HEALTHCARE, HOLOGIC, PHILIPS HEALTHCARE, SEIMENS HEALTHCARE, THOR LABS AND TOSHIBA MEDICAL, amongst others.
Reasons to Purchase this Report
• Current and future Breast cancer imaging Market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Incidences of Breast Cancer
6.1.2 Risisng Investments in R&D of Breast Cancer Diagnostics
6.1.3 Governments Efforts to Incresse Awareness
6.2 Market Restraints
6.2.1 High Cost of Imaging Systems
6.2.2 Errors and Side Effects Associated with Breast Screening
6.2.3 Stringent Regulations
7. Market Segmentation
7.1 By Type of Imaging Modalities
7.1.1 Mammography
7.1.2 MRI
7.1.3 Tomosynthesis
7.1.4 Ultrasound
7.1.5 Molecular Breast Imaging
7.1.6 Optical Breast Imaging
7.1.7 Ductography
7.1.8 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest Of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Barco
9.2 Dilon Diagnostics
9.3 Dune
9.4 GE Healthcare
9.5 Hologic
9.6 Philips Healthcare
9.7 Seimens Healthcare
9.8 Thor Labs
9.9 Toshiba Medical
9.10 List Not Exhaustive
10. Future of the Market